Ovarian cancer, genetic predisposition - panel (CHEK2, NOD2, CYP1B1)
Analysis ID 216
Analysis location “GENESIS” Centre for Medical Genetics
Diagnosed illness Ovarian cancer, genetic predisposition - panel (CHEK2, NOD2, CYP1B1)
OMIM
Clinical information
Type of analysis Molecular
Type of biological material 5 ml of peripheral blood collected in an ETDA tube; DNA sample
Analyzed genes CHEK2; CYP1B1; NOD2 (3020insC)
Analysis description Analysis consists of a testing for the mutations in CHEK2, CYP1B1, and NOD2 genes, which increase the risk of developing ovarian cancer
Analysis indication Familial cases of ovarian cancer
Analysis time 1 - 2 weeks
Refund No
CGM laboratory name Laboratory for Molecular Genetics and Oncology